Related Experiment Video

Updated: May 16, 2026

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

Limited pulmonary MPA, a new MPA entity? A rheumatologist's perspective

Luis F Flores-Suárez1

  • 1Primary Systemic Vasculitides Clinic, Instituto Nacional de Enfermedades Respiratorias, Calzada de Tlalpan 4502. Col. Sección XVI. Tlalpan, C.P. 14080, Mexico City, Mexico. felipe98@prodigy.net.mx.

Clinical and Experimental Nephrology
|November 29, 2012
PubMed

Insights

Microscopic polyangiitis (MPA) often affects the lungs. This review explores evidence for a limited lung-only MPA form, previously misdiagnosed as idiopathic pulmonary fibrosis (IPF).

Area of Science:

  • Pulmonary Medicine
  • Rheumatology
  • Immunology

Background:

  • Microscopic polyangiitis (MPA) commonly presents with lung involvement.
  • Limited forms of MPA, unlike granulomatosis with polyangiitis (Wegener's), are not traditionally recognized.
  • Recent reports suggest lung-exclusive MPA cases, often misdiagnosed as idiopathic pulmonary fibrosis (IPF).

Purpose of the Study:

  • To review evidence supporting the existence of a limited, lung-only form of MPA.
  • To discuss the similarities and differences between this limited MPA and IPF.
  • To clarify diagnostic challenges and improve recognition of pulmonary MPA.

Main Methods:

  • Literature review of case reports and existing studies on MPA and IPF.
  • Comparative analysis of clinical, pathological, and imaging features.
  • Discussion of diagnostic criteria and potential biomarkers.

Main Results:

  • Growing evidence supports MPA limited to the lungs.
  • Significant overlap in presentation between limited MPA and IPF exists.
  • Distinguishing between these conditions can be challenging based on initial presentation.

Conclusions:

  • A distinct entity of microscopic polyangiitis limited to the lungs may exist.
  • Further research is needed to refine diagnostic criteria and differentiate from IPF.
  • Accurate diagnosis is crucial for appropriate treatment and improved patient outcomes.

More Related Videos

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...